Broncus Holding Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRNHF research report →
Price Chart
About the company
Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions. The company's product portfolio is broadly categorized into navigation and treatment solutions.
- CEO
- Hong Xu
- IPO
- 2022
- Employees
- 191
- HQ
- Hangzhou, CN
Get TickerSpark's AI analysis on BRNHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $161.66M
- P/E
- -2.30
- PEG
- 0.12
- P/S
- 25.13
- P/B
- 0.29
- EV/EBITDA
- -1.20
- Div Yield
- 0.00%
- Gross Margin
- -134.59%
- Op Margin
- -1338.82%
- Net Margin
- -1010.89%
- ROE
- -12.45%
- ROIC
- -16.83%
Latest fiscal year · YoY change
- Revenue
- $174.26K-97.9%
- Gross Profit
- $-2,762,079-145.0%
- Op Income
- $-24,427,081
- Net Income
- $-17,901,442-17.0%
- EPS
- $-0.04-19.4%
- OCF Growth
- -0.0%
- FCF Growth
- +2.8%
- 52W High
- $0.31
- 52W Low
- $0.08
- 50D MA
- $0.08
- 200D MA
- $0.08
- Beta
- 1.19
- RSI (14)
- 100
- Avg Volume
- 7.00K
No earnings-call transcripts are available for BRNHF yet.
- Free Float
- 67.5%
- Shares Outstanding
- 526.58M
- Float Shares
- 355.69M
Our BRNHF coverage
Recent articles, reports, and earnings notes.
No research on BRNHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRNHF report →